Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

uBiome preventing heart disease with antimicrobial

AI Biotech/Diagnostics: Other Innovation Patent Forecast®

February 21, 2019

uBiome, located in San Francisco CA, is administering a therapeutically effective amount of a compound for inhibiting CutC and/or CntA enzymes associated with microorganisms. CutC and CntA enzymes are associated with cardiovascular and renal disease.


Relevant Patent Documents

Application US20190050525  

Article Source Link

uBiome


View Patent Forecast®

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.

AI Biotech/Diagnostics: Other Innovation   Patent Forecast®

View Patent Forecast® Top Corporations News and Insights Data Visualization

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.



301